Novo Nordisk wants to innovate in new ways to find cures
The Novo Nordisk CSO wants a new approach to innovation.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Danish pharmaceutical company Novo Nordisk wants to keep innovating and finding new cures, according to a comment made by Novo Nordisk's new Chief Schientific Officer Marcus Schindler at a virtual media event in connection with a conference held by the American Diabetes Association.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pharmacosmos launches cell therapy market offensive
For subscribers
Zealand Pharma sends blood sugar drug to US market
For subscribers
